From: Clinical and bacteriological profile of diabetic foot infections in a tertiary care
| Antimicrobial agents | Proportion susceptible (%) | |||||||
|---|---|---|---|---|---|---|---|---|
| Anaerobic Streptococci | Bacteroides species | Clostridium species | Fusobacterium species | |||||
| n = 18 | (%) | n = 84 | (%) | n = 6 | (%) | n = 5 | (%) | |
| Amoxicillin | – | – | – | – | – | – | – | – |
| Ampicillin/CA | 18 | 100 | 84 | 100 | 6 | 100 | 5 | 100 |
| Erythromycin | 18 | 100 | 25 | 30 | – | – | – | – |
| Cefoxitin | 18 | 100 | 84 | 100 | 6 | 100 | – | – |
| Clindamycin | 12 | 67 | 27 | 32 | – | – | – | – |
| Metronidazole | 18 | 100 | 84 | 100 | 6 | 100 | 5 | 100 |
| Penicillin-G | 18 | 100 | 3 | 4 | 6 | 100 | – | – |
| Piperacillin | 18 | 100 | 75 | 89 | 6 | 100 | – | – |
| Piperacillin/tazobactam | 18 | 100 | 84 | 100 | 6 | 100 | 5 | 100 |
| Tetracycline | – | – | – | – | – | – | – | – |
| Vancomycin | – | – | – | – | – | – | – | – |